Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
ErbB2 and ErbB3 receptors mediate inhibition of calcium-dependent chloride secretion in colonic epithelial cells.
Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.
Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation.
Human colostrum: identification of minor proteins in the aqueous phase by proteomics.
Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB.
Ligand-induced structural transitions in ErbB receptor extracellular domains.
Integral and associated lysosomal membrane proteins.
IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling.
BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells.
Large-scale proteomics and phosphoproteomics of urinary exosomes.
Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-beta-catenin interaction.
Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.
Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Comprehensive analysis of low-abundance proteins in human urinary exosomes using peptide ligand library technology, peptide OFFGEL fractionation and nanoHPLC-chip-MS/MS.
Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation.
Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor.
The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.
Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor.
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.
Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation.
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.
Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners.
The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival.
PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.
A reference map of the human binary protein interactome.
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization.
Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation.
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.
Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity.
Trans-autophosphorylation of activated ligand-responsive EGFR mutant dimers
Non-covalent tyrosine kinase inhibitors bind and inactivate sensitive ligand-responsive EGFR cancer mutants
Covalent tyrosine kinase inhibitors bind and inactivate EGFR kinase domain mutant dimers resistant to non-covalent tyrosine kinase inhibitors
Binding of EGF to ligand-responsive EGFR mutants
EGF-induced dimerization of ligand-responsive EGFR mutants
Binding of SHC1 to p-6Y-EGFR mutants
Binding of CBL to ligand-responsive p-6Y-EGFR mutants
Binding of GRB2:SOS1 complex to phosphorylated ligand-responsive EGFR mutants
SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with ligand-responsive p-6Y-EGFR mutants)
Phosphorylation of SHC1 by ligand-responsive p-6Y-EGFR mutants
Inefficient ubiquitination of ligand-responsive p-6Y-EGFR mutants by p-Y371-CBL
SOS-mediated nucleotide exchange of RAS (mediated by GRB2:SOS1 in complex with phosphorylated SHC1 and ligand-responsive p-6Y-EGFR mutants)
Phosphorylation of CBL by ligand-responsive p-6Y-EGFR mutants
Phosphorylated SHC1 in complex with ligand-responsive p-6Y-EGFR mutants recruits GRB2:SOS1 complex
Covalent tyrosine kinase inhibitors bind and inhibit wild-type EGF:EGFR dimers
Binding of PI3K to complex of GRB2:GAB1 and ligand-responsive p-6Y-EGFR mutants
Conversion of PIP2 to PIP3 by PI3K bound to ligand-responsive p-6Y-EGFR mutants
Binding of GRB2:GAB1 complex to ligand-responsive p-6Y-EGFR mutants
PLCG1 binds to ligand-responsive p-6Y-EGFR mutants
Dissociation of phosphorylated PLCG1 from ligand-responsive p-6Y-EGFR mutants
Phosphorylation of PLCG1 by ligand-responsive p-6Y-EGFR mutants
SHC1 phosphorylation by ERBB2 heterodimers
PIP2 to PIP3 conversion by PI3K bound to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR
Binding of GRB2:GAB1 to p-ERBB2:p-EGFR
Binding of PI3K to GRB2:GAB1 in complex with phosphorylated heterodimer of ERBB2 and EGFR
Sustained activation of SRC kinase by SHP2
Dephosphorylation of Gab1 by SHP2
SHC1 binds to the phosphorylated EGF receptor:ligand complex
Dephosphorylation of PAG by SHP2
PI3K binds to EGF:EGFR:GRB2:GAB1
GAB1 phosphorylation by EGFR kinase
SHC1 phosphorylation by phosphorylated EGFR
SHP2 dephosphorylates Tyr 992 on EGFR
GRB2:SOS1 binds to phosphorylated SHC1 in complex with EGFR
Phosphorylation of EGFR by SRC kinase
SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:GRB2:SOS1)
PI3K converts phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3)
GRB2:GAB1 binds to phosphorylated EGFR
GRB2:SOS1 complex binds to EGF:EGFR complex
Activation of SHP2 through the binding to phospho-Gab1
SOS1-mediated nucleotide exchange of RAS (EGF:EGFR:SHC1:GRB2:SOS1)
Phosphorylation of CBL (EGFR:CBL)
CBL-mediated ubiquitination of CIN85
Sprouty sequesters CBL away from active EGFR
Ubiquitination of stimulated EGFR (CBL)
Assembly of EGFR complex in clathrin-coated vesicles
Beta-Pix:CDC42:GTP binds CBL in EGF:p-6Y-EGFR:CBL:CIN85
Ubiquitination of stimulated EGFR (CBL:GRB2)
CBL ubiquitinates Sprouty
Phosphorylation of CBL (EGFR:GRB2:CBL)
Localization of CBL:GRB2 to the membrane
EGFR non-clathrin mediated endocytosis
CBL escapes CDC42-mediated inhibition by down-regulating the adaptor molecule Beta-Pix
CBL binds and ubiquitinates phosphorylated Sprouty
MATK (CSK homologous kinase) binds phosphorylated ERBB2
Trans-autophosphorylation of p-Y877-ERBB2 heterodimers
Trans-autophosphorylation of ERBB2 heterodimers
SRC family kinases phosphorylate ERBB2
ERBB2 forms heterodimers with ligand-activated ERBB receptors: EGFR, ERBB3 and ERBB4
ERBB4 forms heterodimers with EGFR
Phospholipase C-gamma1 binds to the activated EGF receptor
EGFR activates PLC-gamma1 by phosphorylation
Active PLC-gamma1 dissociates from EGFR
PI3K phosphorylates PIP2 to PIP3
PI3K inhibitors block PI3K catalytic activity
Exocytosis of platelet alpha granule contents
EGFRvIII cancer variant does not bind EGF ligand
RAS GEFs promote RAS nucleotide exchange
Phosphorylated ERBB2 heterodimers bind MEMO1
MEMO1 binds RHOA:GTP:DIAPH1
Activated ERBB2 binds PTK6 (BRK)
ERBB2 promotes PTK6 autophosphorylation
PTPN12 dephosphorylates ERBB2 on tyrosine Y1248
PTPN12 dephosphorylates EGFR at Y1172 (Y1148)
PTPN18 binds ERBB2:EGFR heterodimers
PTPN18 dephosphorylates ERBB2 at Y1196, Y1112 and Y1248
Epsin family proteins bind ubiquitinated cargo
EGFR phosphorylates EPS15
EGFR binds EPS15, EPN1, EPS15L1
PTPN3 dephosphorylates EPS15
F- and N- BAR domain proteins bind the clathrin-coated pit
CLASP proteins and cargo are recruited to the nascent clathrin-coated pit
Clathrin recruits PIK3C2A
Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2
SNX9 recruits components of the actin polymerizing machinery
BAR domain proteins recruit dynamin
SYNJ hydrolyze PI(4,5)P2 to PI(4)P
Endophilins recruit synaptojanins to the clathrin-coated pit
HSPA8-mediated ATP hydrolysis promotes vesicle uncoating
Clathrin recruits auxilins to the clathrin-coated vesicle
Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle
Dynamin-mediated GTP hydrolysis promotes vesicle scission
Dissociation of clathrin-associated proteins
Dissociation of AAK1 and dephosphorylation of AP-2 mu2
RAB5 and GAPVD1 bind AP-2
CIN85 dissociates from EGF:p-6Y-EGFR:CBL:Beta-Pix:CDC42:GTP:CIN85
EGFR phosphorylates NOTCH3
NOTCH3 binds activated EGFR
PTK2 binds activated EGFR
PTK2 autophosphorylates downstream of EGFR
ERBB2 KD mutants heterodimerize
ERBB2 KD mutants trans-autophosphorylate
Phosphorylated heterodimers of ERBB2 KD mutants and EGFR bind GRB2:GAB1
Phosphorylated heterodimers of ERBB2 KD mutants and EGFR, in complex with GRB2:GAB1, bind PI3K
PI3K bound to phosphorylated heterodimers of ERBB2 KD mutants and EGFR converts PIP2 to PIP3
Phosphorylated heterodimers of ERBB2 KD mutants bind SHC1
Phosphorylated heterodimers of ERBB2 KD mutants phosphorylate SHC1
Phosphorylated heterodimers of ERBB2 KD mutants recruit GRB2:SOS1 through SHC1
RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 KD mutants
Phosphorylated heterodimers of ERBB2 KD mutants and EGFR bind GRB2:SOS1
RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 KD mutants and EGFR
Phosphorylated heterodimers of ERBB2 KD mutants and EGFR phosphorylate PLCG1
Phosphorylated heterodimers of ERBB2 KD mutants and EGFR bind PLCG1
ERBB2 ECD mutants heterodimerize with EGFR
Heterodimers of ERBB2 ECD mutants and EGFR trans-autophosphorylate
RAS guanyl nucleotide exchange mediated by the p-6Y- ERBB2 ECD mutants:EGF:p-6Y-EGFR:p-SHC1:GRB2:SOS1
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate SHC1
PI3K bound to phosphorylated heterodimers of ERBB2 ECD mutants and EGFR converts PIP2 to PIP3
RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 ECD mutants and EGFR through GRB2
GRB2:SOS1 binds to phosphorylated heterodimers of ERBB2 ECD mutants and EGFR
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR bind PLCG1
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR phosphorylate PLCG1
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR recruit GRB2:SOS1 through SHC1
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR, in complex with GRB2:GAB1, bind PI3K
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR bind SHC1
Phosphorylated heterodimers of ERBB2 ECD mutants and EGFR bind GRB2:GAB1
ERBB2 TMD/JMD mutants hetrodimerize
Phosphorylated heterodimers of ERBB2 TMD/JMD mutants and EGFR bind GRB2:SOS1
Phosphorylated heterodimers of ERBB2 TMD/JMD mutants recruit GRB2:SOS1 through SHC1
RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 TMD/JMD mutants
Phosphorylated ERBB2 TMD/JMD heterodimers bind SHC1
Phosphorylated heterodimers of ERBB2 TMD/JMD mutants and EGFR phosphorylate PLCG1
Phosphorylated heterodimers of ERBB2 TMD/JMD mutants phosphorylate SHC1
Phosphorylated heterodimers of ERBB2 TMD/JMD mutants and EGFR bind PLCG1
RAS activation by SOS1 bound to phosphorylated heterodimers of ERBB2 TMD/JMD mutants and EGFR
ERBB2 TMD/JMD heterodimers trans-autophosphorylate
NFE2L2 dependent EGF expression
Shc1 binds phosphorylated ERBB2:EGFR heterodimers
Plcg1 binds P-ERBB2:P-EGFR
Plcg1 phosphorylation by P-ERBB2:P-EGFR